Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Here, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines the importance of regulation when a novel therapy such as CAR T-cell therapy is introduced, and what to expect from the regulatory session taking place on Day 2 of the 2nd European CAR T-cell Meeting in Sitges, Spain.